U.S. PHARMACOPEIA

Search USP29  
Benzonatate Capsules
» Benzonatate Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of benzonatate C30H53NO11 av.
Packaging and storage— Preserve in tight, light-resistant containers.
Identification—
A: The contents of the Capsules meet the requirements of Identification test A under Benzonatate. If a difference is observed, or if excipients are present, use an amount of the contents of Capsules equivalent to about 100 mg of benzonatate, mixed with 25 mL of 0.01 N hydrochloric acid, and proceed as directed under Identification—Organic Nitrogenous Bases 181, beginning with “Transfer the liquid to a separator.”
B: The contents of the Capsules respond to Identification test B under Benzonatate.
Uniformity of dosage units 905: meet the requirements.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay
Standard preparation— Transfer about 50 mg of USP Benzonatate RS, accurately weighed, to a 100-mL volumetric flask, dilute with water to volume, and mix.
Assay preparation— Mix a number of Capsules, equivalent to about 500 mg of benzonatate, with 40 mL of chloroform in a suitable high-speed blender, and dilute with chloroform to 100.0 mL. Transfer 10.0 mL of this solution, equivalent to about 50 mg of benzonatate, to a 100-mL volumetric flask, and evaporate the chloroform on a steam bath with the aid of a current of air. Dissolve the residue in water, dilute with water to volume, and mix.
Procedure— Transfer 4.0 mL each of the Standard preparation, the Assay preparation, and water to provide the blank, to separate test tubes. To each tube add in succession 1.0 mL of 1 M hydroxylamine hydrochloride and 1.0 mL of 3.5 N sodium hydroxide, mixing after each addition. Allow to stand for 10 minutes, accurately timed, then add 1.0 mL of 3.5 N hydrochloric acid, mix, add 1.0 mL of ferric chloride solution (8 in 100), and mix. Allow to stand for 30 minutes, accurately timed. Gently swirl the tubes for 1 minute to remove any gas bubbles present, then concomitantly determine the absorbances of the solutions in 1-cm cells, at the wavelength of maximum absorbance at about 500 nm, with a suitable spectrophotometer, using the blank to set the instrument. Calculate the quantity, in mg, of benzonatate (C30H53NO11 av.) in the number of Capsules taken by the formula:
C(AU / AS),
in which C is the concentration, in µg per mL, of USP Benzonatate RS in the Standard preparation; and AU and AS are the absorbances of the solutions from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Clydewyn M. Anthony, Ph.D., Scientist
Expert Committee : (MDCCA05) Monograph Development-Cough Cold and Analgesics
USP29–NF24 Page 256
Phone Number : 1-301-816-8139